HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanisms underlying the metabolic actions of galegine that contribute to weight loss in mice.

AbstractBACKGROUND AND PURPOSE:
Galegine and guanidine, originally isolated from Galega officinalis, led to the development of the biguanides. The weight-reducing effects of galegine have not previously been studied and the present investigation was undertaken to determine its mechanism(s) of action.
EXPERIMENTAL APPROACH:
Body weight and food intake were examined in mice. Glucose uptake and acetyl-CoA carboxylase activity were studied in 3T3-L1 adipocytes and L6 myotubes and AMP activated protein kinase (AMPK) activity was examined in cell lines. The gene expression of some enzymes involved in fat metabolism was examined in 3T3-L1 adipocytes.
KEY RESULTS:
Galegine administered in the diet reduced body weight in mice. Pair-feeding indicated that at least part of this effect was independent of reduced food intake. In 3T3-L1 adipocytes and L6 myotubes, galegine (50 microM-3 mM) stimulated glucose uptake. Galegine (1-300 microM) also reduced isoprenaline-mediated lipolysis in 3T3-L1 adipocytes and inhibited acetyl-CoA carboxylase activity in 3T3-L1 adipocytes and L6 myotubes. Galegine (500 microM) down-regulated genes concerned with fatty acid synthesis, including fatty acid synthase and its upstream regulator SREBP. Galegine (10 microM and above) produced a concentration-dependent activation of AMP activated protein kinase (AMPK) in H4IIE rat hepatoma, HEK293 human kidney cells, 3T3-L1 adipocytes and L6 myotubes.
CONCLUSIONS AND IMPLICATIONS:
Activation of AMPK can explain many of the effects of galegine, including enhanced glucose uptake and inhibition of acetyl-CoA carboxylase. Inhibition of acetyl-CoA carboxylase both inhibits fatty acid synthesis and stimulates fatty acid oxidation, and this may to contribute to the in vivo effect of galegine on body weight.
AuthorsM H Mooney, S Fogarty, C Stevenson, A M Gallagher, P Palit, S A Hawley, D G Hardie, G D Coxon, R D Waigh, R J Tate, A L Harvey, B L Furman
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 153 Issue 8 Pg. 1669-77 (Apr 2008) ISSN: 0007-1188 [Print] England
PMID18297106 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fatty Acids
  • Guanidines
  • Multienzyme Complexes
  • Protein Serine-Threonine Kinases
  • AMP-Activated Protein Kinases
  • Acetyl-CoA Carboxylase
  • Glucose
  • galegine
Topics
  • AMP-Activated Protein Kinases
  • Acetyl-CoA Carboxylase (antagonists & inhibitors, metabolism)
  • Animals
  • Cell Line
  • Eating (drug effects)
  • Fatty Acids (metabolism)
  • Galega (chemistry)
  • Gene Expression Regulation, Enzymologic (drug effects)
  • Glucose (metabolism)
  • Guanidines (pharmacology)
  • Humans
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Multienzyme Complexes (drug effects, metabolism)
  • Protein Serine-Threonine Kinases (drug effects, metabolism)
  • Rats
  • Weight Loss (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: